0001209191-18-056046.txt : 20181024
0001209191-18-056046.hdr.sgml : 20181024
20181024161659
ACCESSION NUMBER: 0001209191-18-056046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181022
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ASTRAZENECA PLC
CENTRAL INDEX KEY: 0000901832
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181136575
BUSINESS ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
BUSINESS PHONE: 011 44 20 7304 5000
MAIL ADDRESS:
STREET 1: 1 FRANCIS CRICK AVENUE
STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB2 0AA
FORMER NAME:
FORMER CONFORMED NAME: ZENECA GROUP PLC
DATE OF NAME CHANGE: 19930422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zeneca, Inc.
CENTRAL INDEX KEY: 0001657583
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181136576
BUSINESS ADDRESS:
STREET 1: 1800 CONCORD PIKE
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 800-236-9933
MAIL ADDRESS:
STREET 1: 1800 CONCORD PIKE
CITY: WILMINGTON
STATE: DE
ZIP: 19803
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-22
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0000901832
ASTRAZENECA PLC
1 FRANCIS CRICK AVENUE
CAMBRIDGE
X0
CB2 0AA
UNITED KINGDOM
0
0
1
0
0001657583
Zeneca, Inc.
C/O ASTRAZENECA PLC
1 FRANCIS CRICK AVENUE
CAMBRIDGE
X0
CB2 0AA
UNITED KINGDOM
0
0
1
0
Common Stock
2018-10-22
4
C
0
2404554
A
2404554
I
By Zeneca, Inc.
Common Stock
2018-10-22
4
P
0
600000
5.00
A
3004554
I
By Zeneca, Inc.
Warrants to Purchase Series C-1 Preferred Stock
0.12
2018-10-22
4
X
0
113891
0.00
D
Series C-1 Preferred Stock
113891
0
I
By Zeneca, Inc.
Series C-1 Preferred Stock
2018-10-22
4
X
0
113891
0.12
A
Common Stock
113891
1666951
I
By Zeneca, Inc.
Series C-1 Preferred Stock
2018-10-22
4
S
0
2734
5.00
D
Common Stock
2734
1664217
I
By Zeneca, Inc.
Series C-1 Preferred Stock
2018-10-22
4
C
0
1664217
0.00
D
Common Stock
1664217
0
I
By Zeneca, Inc.
Series D Preferred Stock
2018-10-22
4
C
0
740337
0.00
D
Common Stock
740337
0
I
By Zeneca, Inc.
Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date.
Zeneca Inc. is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the securities held by Zeneca Inc., but disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, if any.
Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering.
The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering.
/s/ Adrian Kemp, on behalf of AstraZeneca PLC
2018-10-24
/s/ David E. White, on behalf of Zeneca Inc.
2018-10-24